Aviv Bniya 2025: Asset Sales Unlocked Cash, but the Development Engine Has Not Restarted

Company Introduction

At first glance, Aviv Bniya looks like a fairly standard Jerusalem-based residential developer with a small income-producing real estate side business. That is only a partial read. In practice, the company enters 2026 after a very weak year in development activity, but also after two post-balance-sheet disposals that changed its cash position almost overnight. This is exactly the kind of case where the real question is not whether value was created, but which part of that value actually became accessible cash for shareholders and which part is still only a future option.

What is working right now is fairly clear. The company did not end 2025 under covenant pressure, the Givat Shaul asset was sold and the transaction closed in March 2026, the Hungary land was sold and that deal also closed in early March 2026, and the Narkisim project in Rishon LeZion is already at the end of its delivery cycle. That is a real base for stabilization.

But the active bottleneck is just as clear: the development engine itself has not restarted cleanly. Construction and real estate revenue fell to NIS 154.7 million in 2025 from NIS 356.0 million a year earlier, the gross margin in that segment fell to 6.88% from 14.0%, and customer advances and contract liabilities dropped to just NIS 10.7 million from NIS 57.6 million. In other words, much of 2025 cash flow came from collecting cash on advanced projects, not from building a strong new sales cycle.

That matters now because of the market layer too. With a market cap of about NIS 299 million in the latest market snapshot, and with the two post-balance-sheet disposals generating about NIS 225.5 million of free cash combined, it is easy to read Aviv as a value-unlocking story. That is only half the picture. At the same time, the company sold the asset that carried most of its NOI, the net operating income from properties, while much of the future development value sits in 2028 projects that still have no signed sales.

The economic map looks like this:

This chart captures the problem well. Aviv did not end 2025 as a growth company that merely slowed down. It ended the year with a sharp cut in revenue, profit and near-term backlog quality. The right reading today is therefore not “back on track,” but “a company that bought itself time.”

Events And Triggers

The first trigger: the Givat Shaul sale. The transaction was signed in December 2025 for NIS 216 million plus VAT and closed on March 16, 2026. According to the company, the sale generated about NIS 183 million of free cash. That materially improves financing flexibility, but it also removes the core asset that carried most of the recurring income base.

The second trigger: the Hungary land sale. The six plots in Budapest were sold for EUR 12.95 million, about NIS 47.4 million. The agreement became effective on February 26, 2026 and the deal closed on March 2, 2026. The company estimates about NIS 42.5 million of free cash and a pretax gain of roughly NIS 27 million in the first quarter of 2026. Again, this is a capital-structure event, not proof that the Israeli operating business has already turned.

The third trigger: the purchase-tax refund case. After adopting the court ruling with the tax authority, Aviv estimates it may receive a refund and recognize about NIS 4.4 million of pretax profit. This is a secondary trigger, but it follows the same pattern: 2026 opens with several balance-sheet-relief items even without an immediate change in underlying operating quality.

The fourth trigger: the market already received an external warning sign in 2025. Midroog downgraded Bond Series 7 in July 2025 from Baa1.il with a negative outlook to Baa2.il with a stable outlook, and the fixed coupon stepped up to 7.15%. That is not a sign of immediate stress, but it does show that the external credit lens read 2025 as less clean than the covenant picture alone suggests.

This chart matters because it exposes how concentrated the portfolio was. Givat Shaul represented roughly 81% of Aviv’s investment property value at the end of 2025. On an NOI basis the picture was even sharper: the asset generated NIS 11.3 million of NOI out of NIS 13.5 million for the whole segment, or roughly 84% of the recurring property income base. That is why the sale cuts both ways. It unlocked accessible value, but at the same time it weakened recurring earnings.

That also explains what the market may miss on first read. The easy headline is “a lot of cash is coming in.” The more accurate headline is “a lot of cash is coming in, but it is replacing a recurring asset rather than being added on top of one.”

Efficiency, Profitability And Competition

The core insight is that 2025 weakness was not only about lower volume. Profit quality weakened as well. Total revenue fell to NIS 170.2 million from NIS 370.5 million, but the sharper issue sat inside the development segment: construction and real estate revenue fell to NIS 154.7 million from NIS 356.0 million, while the gross margin in that segment dropped to 6.88% from 14.0%.

That is a combined price, volume and terms story. The company describes a market environment of high rates, slower sales, Bank of Israel restrictions on financing promotions, a 5.1% increase in the construction input index in 2025, and labor shortages. Aviv had to operate in that environment while offering easier payment terms to buyers. The company estimated financing benefits granted in payment schedules in 2023 through 2025 at NIS 8.176 million, and customer loans subsidized by banks totaled about NIS 6.109 million at a company cost of roughly NIS 239 thousand. The cost directly attributed to 2025 sales themselves was fairly low, around NIS 537 thousand, but that does not change the broader picture: the sector is running on softer commercial terms than before.

The chart makes clear how dominant the development side still is. Rental revenue rose to NIS 15.5 million in 2025 from NIS 14.5 million, and segment NOI was broadly stable at NIS 13.5 million versus NIS 13.7 million a year earlier. But that was nowhere close to enough to offset the collapse in development turnover.

The detail that many readers may miss is the fourth quarter. On the surface, fourth-quarter net profit fell only to NIS 9.7 million from NIS 13.0 million in the comparable quarter, a milder decline than the full-year deterioration. But the quarter also included NIS 9.812 million of fair-value gains on investment property. Without the revaluation of Givat Shaul and Agripas, the final quarter would have looked much weaker. That is not a clean operating recovery.

There is also a labor warning sign inside the report. Headcount fell to 129 from 237 a year earlier, and the execution department alone dropped to 70 employees from 173. The company explains that through the loss of Palestinian workers and greater reliance on manpower companies and subcontractors. The economic meaning is twofold: less direct control over execution, and more exposure to external labor pricing exactly when labor costs are already under pressure.

That matters for the next cycle as well. A superficial look at Aviv’s land inventory could lead investors to think the issue is only demand. The filing shows that labor availability and execution cost are also real bottlenecks. That is especially important for projects where full execution agreements have not yet been signed, because that is where gross-profit assumptions can still move.

Cash Flow, Debt And Capital Structure

This is where framing discipline matters. The relevant lens for Aviv right now is the full cash picture, meaning how much cash was actually left after the period’s real uses, not a narrow reading of operating cash flow alone. The reason is simple: the thesis here is about balance-sheet flexibility, refinancing room and the ability to buy time.

On that reading, 2025 was not yet a strong year. Operating cash flow was NIS 57.4 million and investing cash flow was positive NIS 51.3 million, but that investing inflow included a NIS 35 million advance from the Givat Shaul sale and NIS 18.9 million released from restricted project-account cash. Financing cash flow was negative NIS 118.4 million, mainly because of a NIS 56.25 million bond repayment and NIS 55.1 million of net bank-credit repayment. The bottom line is that cash still fell by NIS 9.7 million during the year.

The more important point is what created operating cash flow. The company says it came mainly from collecting from customers in projects that were completed or close to completion. That fits well with the sharp decline in contract assets to NIS 37.5 million from NIS 171.0 million and the collapse in customer advances to NIS 10.7 million from NIS 57.6 million. Put differently, 2025 generated cash because Aviv collected money from older deals, not because it rebuilt a strong new sales engine.

Positive working capital also needs to be unpacked. Aviv ended 2025 with positive working capital of about NIS 178.6 million, or NIS 161.5 million after 12-month adjustments, but that includes NIS 174 million of investment property held for sale and NIS 40 million of cash. So the positive liquidity picture at year-end leaned heavily on the Givat Shaul classification and on disposals that were already in motion, not only on the recurring cash-generation power of the operating business.

This chart sharpens an important change in financing structure. Customer advances nearly disappeared, bonds declined after repayment, bank credit eased only modestly, but suppliers and other payables rose to NIS 174.5 million from NIS 124.5 million. That is not an immediate stress picture, but it is a picture of a cycle in which less working capital is funded by customers.

On the other hand, and this is what keeps the story from becoming a distress case, there is no covenant squeeze here.

The maturity profile also improved in the short term. Short-term bank debt fell to NIS 25.0 million from NIS 160.7 million, mainly because facilities were extended, while long-term bank debt rose to NIS 379.1 million. At the same time, Bond Series 7 remained at NIS 112.5 million par, with a fixed 7.15% coupon after the downgrade. This is not a light capital structure, but it is one that bought itself breathing room.

The more interesting gap is the gap between value created and value accessible. Givat Shaul and Hungary together released roughly NIS 225.5 million of free cash after the balance sheet date. Against a market cap of about NIS 299 million, that is a very meaningful number. But once Givat Shaul is out of the system, the recurring income base becomes much smaller. That is the heart of the story. Aviv unlocked value, but now it has to prove that it can build the next phase rather than just monetize the prior one.

Outlook And Forward View

Before going into detail, there are five findings that should stay in the reader’s head:

• The signed revenue base that remains to be recognized after December 31, 2025 is very small: only NIS 13.6 million of revenue and NIS 3.5 million of gross profit.
• Most of the future profit the company shows sits in 2028 projects that still have no signed sales, especially Netanya, Kiryat Gat and Be'er Yaakov.
• Narkisim, the most advanced project, is mainly a closeout-and-collection story, not the start of a new cycle.
• 2026 may look very strong at the reported level because of disposals and capital gains even if the operating business stays soft.
• After the Givat Shaul sale, reading Aviv as a stable income-producing real estate story is simply less accurate than it used to be.

This is probably the single most important chart in the filing. It explains why potential value should not be confused with near-term earnings.

What 2026 Actually Has Left

Narkisim in Rishon LeZion was 97.6% complete, with 286 signed units out of 315, and an expected construction completion date of March 2026. That project should help Aviv close out 2026 with deliveries, collections and about NIS 15.8 million of gross profit still to be recognized. That matters, but it is not enough to build a growth year on its own.

The reason is that the signed backlog section is very thin. After the balance sheet date, expected revenue from binding sales contracts totals only NIS 13.6 million, and the gross profit still to be recognized from those contracts is only NIS 3.5 million. For a residential developer, that says something very simple: the company entered 2026 with very little signed revenue left to recognize.

Where The Future Value Sits

The larger value sits in projects that have not really opened commercially yet.

Netanya is where the biggest value engine sits. The Havatzelet project carries expected gross profit of NIS 131.2 million and expected surplus available for extraction of NIS 149.5 million, but as of year-end not a single unit had been signed. At the same time, the project carries NIS 135.5 million of credit, at prime plus 0.5% to 1.0%, with the facility maturity extended to February 4, 2027. The meaning is clear: there is a large development option here, but it has not yet become near-term earnings.

Kiryat Gat and Be'er Yaakov tell a similar story on a smaller scale. Together they hold NIS 87.5 million of unrecognized gross profit, and both are targeted for 2028 with no signed sales at the report date. So when a reader sees NIS 234.5 million of unrecognized gross profit across the four very material projects, an immediate asterisk is needed: most of it is not near-term, and most of it is not yet contract-backed.

What Remains On The Rental Side

After Givat Shaul, the recurring property base becomes much narrower. Window to Jerusalem on Agripas ended 2025 with fair value of NIS 41.5 million, occupancy of 96%, NOI of roughly NIS 3.0 million, and one anchor tenant occupying 56% of the space. That is a relatively stable asset, but it cannot by itself replace what Givat Shaul contributed. So anyone describing Aviv as a company with a recurring-property anchor needs to be precise: there was such an anchor, and it has now been sold.

Belilius Is Not A Replacement Yet

Belilius and New Talpiot are an interesting value pocket, but not one that already carries the thesis. Aviv’s direct share in Buildings 7 and 8 amounts to 9.6 units, with 67% completion, and in Buildings 5 and 6 to another 9.6 units with only 7.8% completion. The company recorded NIS 2.0 million of profit from equity-accounted investments in 2025, mainly from progress in the Talpiot project. That is useful, but it is still not a true replacement for either Givat Shaul or the core self-developed pipeline.

That is why 2026 should be defined as a bridge year with proof requirements. It is not a reset year, because the disposals have already improved the balance sheet. But it is not a breakout year either, because the new engine is still unsigned.

What has to happen over the next two to four quarters for the reading to improve?

• Aviv has to turn Netanya, Kiryat Gat and Be'er Yaakov from land inventory with theoretical future profit into signed sales on acceptable terms.
• The company has to show that the cash unlocked by disposals is being translated into a better-quality pipeline, not just temporary balance-sheet relief.
• After Givat Shaul leaves the system, the next reports have to show what recurring operating earnings are actually left.
• If the purchase-tax refund progresses, it can help, but it cannot become the core thesis by itself.

Risks

The first risk is the illusion of an overly strong 2026. The next few quarters could look good because of the roughly NIS 27 million pretax gain from Hungary, the NIS 183 million free cash from Givat Shaul, and the possible NIS 4.4 million purchase-tax benefit. Those are real events, but they do not prove that the development engine has already restarted.

The second risk is future earnings quality. Both the company and the auditors put clear emphasis on cost-to-complete estimates for buildings held for sale. That is not a technical footnote. In a housing market facing labor pressure, worker shortages, higher construction inputs and financing promotions, cost estimates are one of the first places where future profit can erode.

The third risk is value concentration in projects that are still unsold. Netanya alone holds a very large profit opportunity, but also high sensitivity to demand, pricing and financing. If the market requires further concessions to customers, or if sales progress is delayed, a large part of the value could remain on paper for quite a while.

The fourth risk is the weakening of the recurring rental base after the sale. Givat Shaul was a real asset with NIS 11.3 million of NOI and 86.7% occupancy. After the sale, Aviv becomes more dependent on development and less dependent on recurring income. That may improve flexibility, but it also increases volatility.

The fifth risk is actionability in the stock itself. The latest daily trading turnover in the share was only NIS 3,186, while short interest stands at 0.04% of float with an SIR of 0.11. This is not a stock with aggressive short positioning, but it is a very illiquid one, which means the price may react slowly even to real improvement.

Conclusions

Aviv Bniya does not exit 2025 as a company with strong operating momentum. It exits the year as a weaker operating business that nevertheless completed two post-balance-sheet monetizations which give it real breathing room. That is an important change, but it does not cancel the fact that the recurring base is smaller now and that the larger future profit pool still sits in 2028 projects.

The current thesis in one line: Aviv moved from a situation where value was locked inside assets to a situation where value turned into cash, but it now has to prove that it can turn that cash into a new and higher-quality development cycle.

What changed versus the simplistic read of the company is not only the balance sheet but the type of story. This is now less of an income-producing real estate company with a development add-on, and more of a residential developer that bought itself time through disposals. The strongest counter-thesis is that the market is pricing only the weakness of 2025 and missing a company with NIS 374 million of equity, comfortable covenants, roughly NIS 225.5 million of free cash unlocked after the balance sheet date, and a development pipeline that could look very different if sales normalize. That is an intelligent thesis, but it still needs proof.

What could change the market reading in the short to medium term is not another monetization headline. The market will want to see three things: signed sales in the 2028 projects, disciplined capital deployment of the cash that was freed up, and operating results that do not rely mainly on revaluations and capital gains. If that happens, the reading on Aviv could change relatively quickly. If it does not, 2026 will remain a year that looks good in cash terms but not good enough in the core business.

Why this matters: Aviv is a clean test of the difference between a company that unlocked value through asset sales and a company that has already rebuilt its next earnings engine. Right now, the first part has happened. The second part is still open.